Jul 16, 2012
Autotelic Lab will be presenting data on its platform of expanded range point-of-care diagnostic devices
Jul 16, 2012
Autotelic Lab will be presenting data on its platform of expanded range point-of-care diagnostic devices
Jul 02, 2012
Autotelic Lab will be presenting data on its platform of expanded range point-of-care diagnostic devices
Jun 18, 2012
Autotelic Lab will be presenting data on point of care diagnostic devices for FSH and BNP as potential diagnostic biomarker screening for ovarian cancer
Apr 09, 2012
Biomiga Diagnostics will be presenting data on its population pharmacokinetic/Therapeutic Monitoring Device for Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH), and Human chorionic gonadotropin (hCG) in personalized IVF treatment.
Mar 06, 2012
Biomiga Diagnostics will be presenting data on its population pharmacokinetic/Therapeutic Monitoring Device designed for Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) with application to other protein therapeutics.
Mar 02, 2012
Biomiga Diagnostics announces the development of lateral flow point-of-care Therapeutic Drug Monitoring (TDM) assays for Luteinizing Hormone (LH) and Follicle Stimulating Hormone (FSH). These findings will be presented at the AACR 2012
Jan 02, 2012
Biomiga Diagnostics announced the appointment of Kevin Wang to Director of IT and the launch of its website aiming at improving awareness of Therapeutic Drug Monitoring (TDM) in personalized medicine.
Nov 21, 2011
Biomiga Diagnostics, maker of quantitative point-of-care tests for Therapeutic Drug Monitoring and biomarker testing to promote personalized medicine, today announced it is joining Astia, a global network serving women-led high growth start-ups.
Jul 20, 2011
Biomiga Diagnostics signed purchasing agreement with Blue Cross-Biomedical, a pioneer in colloidal gold rapid diagnostic tests, to further its mission of personalized medicine.